The tweet was deleted by the author.
But we saved everything 🙂.
Patrick Soon-Shiong discusses Anktiva's role in cancer immunotherapy
Patrick Soon-Shiong, renowned healthcare entrepreneur and physician, has concluded an extensive discussion regarding the impact of Anktiva on expanding key immune cells such as NK cells and T cells.
As part of cancer immunotherapy, NK and T cells are known as critical elements in the body's defense mechanism against cancer cells. Anktiva, a medical treatment currently under study, aims to enhance the proliferation of these cells, potentially improving patient outcomes.
Soon-Shiong's discussion emphasizes the 'irrefutable' role these immune cells play in 'killing cancer.' An upcoming detailed broadcast is expected to shed further light on the treatment's implications, featuring insights from medical experts and personal testimonies from patients. The broadcast is anticipated to provide a comprehensive overview of the treatment, its mechanisms, and its future potential in cancer therapy.
The latest developments surrounding Anktiva build upon Patrick Soon-Shiong’s prior advances, including the release of groundbreaking lung cancer trial data indicating that PDL1 levels do not affect NK cells, which offered critical insights into immune cell dynamics within oncology. Additionally, the ongoing exploration of combination therapies, such as the strategy for uniting Anktiva with Pluvicto in the context of prostate cancer, continues to shape the evolving landscape of immunotherapy and regulatory pathways.
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Subscribe to TU news
Did you like the article?
Latest Patrick Soon-Shiong News
Weekly Top Bonuses
Top News
Top 5 companies for you
United States
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
Live News
